Insiders Updates
Rise in RIGL’s short interest indicates Bearish sentiment
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Rigel Pharmaceuticals’s recently made public that its EVP & Chief Financial Officer Schorno Dean L unloaded Company’s shares for reported
Rigel Pharmaceuticals Inc. (RIGL), a biotechnology company specializing to manufacture and commercialize novel molecule drugs, soared 12.14% at $3.46 in